Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 29017278.
- Also identified by DOI 10.1093/cid/cix406 and PMC identifier 5682919.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Two patients with Lassa fever are described who are the first human cases treated with a combination of ribavirin and favipiravir. Both patients survived but developed transaminitis and had prolonged detectable virus RNA in blood and semen, suggesting that the possibility of sexual transmission of Lassa virus should be considered.
Medical subject headings
- Amides
- Antiviral Agents
- Lassa Fever
- Pyrazines
- Ribavirin